Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Thyroid cancer
Closed
Phase 2/3
This trial is looking at using near-infrared fluorescence imaging during thyroid surgery to avoid removing or damaging the parathyroid glands.
It is open to people who are having all of their thyroid gland removed. It is also open for people who have had part of their thyroid gland removed and are having surgery to remove the remaining lobe of their thyroid.
Recruitment start: 13 May 2022
Recruitment end: 15 January 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Saba Balasubramanian
Clinical Trials Research Unit (CTRU), University of Leeds
Sheffield Teaching Hospitals NHS Foundation Trust
NIHR Efficacy and Mechanism Evaluation (EME) Programme
Last reviewed: 8 February 2024
CRUK internal database number: 17383